Literature DB >> 11606267

Prion diseases: dynamics of the infection and properties of the bistable transition.

N Kellershohn1, M Laurent.   

Abstract

Prion diseases are thought to result from a pathogenic, conformational change in a cellular protein, the prion protein. The pathogenic isoform seems to convert the normal isoform in an autocatalytic process. In contrast to the conditions used for in vitro studies of enzyme kinetics, the concentration of the catalyst is not much lower than that of the substrate in the course of infection. This feature may endow the system with a time-hierarchy allowing the pathogenic isoform to relax very slowly in the course of infection. This may contribute to the long incubation periods observed in prion diseases. The dynamic process of prion propagation, including turnover of the cellular prion protein, displays bistable properties. Sporadic prion diseases may result from a change in one of the parameters associated with metabolism of the prion protein. The bistable transition observed in sporadic disease is reversible, whereas that observed in cases of exogenous contamination is irreversible. This model is consistent with the occurrence of rare, sporadic forms of prion diseases. It may also explain why only some individuals of a cohort develop a prion disease following transient food contamination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606267      PMCID: PMC1301721          DOI: 10.1016/S0006-3495(01)75897-3

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  35 in total

1.  Autocatalytic processes in cooperative mechanisms of prion diseases.

Authors:  M Laurent
Journal:  FEBS Lett       Date:  1997-04-21       Impact factor: 4.124

2.  Physical properties of the Creutzfeldt-Jakob disease agent.

Authors:  T K Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Apparent co-operativity for highly concentrated Michaelian and allosteric enzymes.

Authors:  M Laurent; N Kellershohn
Journal:  J Mol Biol       Date:  1984-04-15       Impact factor: 5.469

Review 4.  Molecular clues to pathogenesis in prion diseases.

Authors:  M Laurent; G Johannin
Journal:  Histol Histopathol       Date:  1997-04       Impact factor: 2.303

5.  Pharmacological manipulation of early PrPres accumulation in the spleen of scrapie-infected mice.

Authors:  V Beringue; F Lamoury; K T Adjou; T Maignien; M Demoy; P Couvreur; D Dormont
Journal:  Arch Virol Suppl       Date:  2000

6.  The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele.

Authors:  E Fernandez-Bellot; E Guillemet; C Cullin
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

7.  Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.

Authors:  G C Telling; P Parchi; S J DeArmond; P Cortelli; P Montagna; R Gabizon; J Mastrianni; E Lugaresi; P Gambetti; S B Prusiner
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

8.  The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments.

Authors:  H K Edskes; V T Gray; R B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.

Authors:  N Kellershohn; M Laurent
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

10.  Non-genetic propagation of strain-specific properties of scrapie prion protein.

Authors:  R A Bessen; D A Kocisko; G J Raymond; S Nandan; P T Lansbury; B Caughey
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

View more
  10 in total

1.  Protein aggregation/folding: the role of deterministic singularities of sequence hydrophobicity as determined by nonlinear signal analysis of acylphosphatase and Abeta(1-40).

Authors:  Joseph P Zbilut; Alfredo Colosimo; Filippo Conti; Mauro Colafranceschi; Cesare Manetti; MariaCristina Valerio; Charles L Webber; Alessandro Giuliani
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

2.  Theoretical modeling of prion disease incubation.

Authors:  R V Kulkarni; A Slepoy; R R P Singh; D L Cox; F Pázmándi
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

3.  A model of threshold behavior reveals rescue mechanisms of bystander proteins in conformational diseases.

Authors:  Conner I Sandefur; Santiago Schnell
Journal:  Biophys J       Date:  2011-04-20       Impact factor: 4.033

4.  Thalamocortical bistable switch as a theoretical model of fibromyalgia pathogenesis inferred from a literature survey.

Authors:  Ilaria Demori; Giulia Giordano; Viviana Mucci; Serena Losacco; Lucio Marinelli; Paolo Massobrio; Franco Blanchini; Bruno Burlando
Journal:  J Comput Neurosci       Date:  2022-07-11       Impact factor: 1.453

5.  Kinetic logic: a tool for describing the dynamics of infectious disease behavior.

Authors:  Claire Martinet-Edelist
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

6.  Global analysis of dynamical decision-making models through local computation around the hidden saddle.

Authors:  Laura Trotta; Eric Bullinger; Rodolphe Sepulchre
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

7.  Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition.

Authors:  Veronica Musante; Lu Li; Jean Kanyo; Tukiet T Lam; Christopher M Colangelo; Shuk Kei Cheng; A Harrison Brody; Paul Greengard; Nicolas Le Novère; Angus C Nairn
Journal:  Elife       Date:  2017-06-14       Impact factor: 8.140

8.  A general hypothesis of multistable systems in pathophysiology.

Authors:  Bruno Burlando
Journal:  F1000Res       Date:  2022-08-05

9.  The smallest chemical reaction system with bistability.

Authors:  Thomas Wilhelm
Journal:  BMC Syst Biol       Date:  2009-09-08

10.  A mechanism for bistability in glycosylation.

Authors:  Andrew G McDonald; Keith F Tipton; Gavin P Davey
Journal:  PLoS Comput Biol       Date:  2018-08-03       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.